These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9631730)

  • 1. [Lymphocyte apoptosis--one of mechanisms of specific immunotherapy of atopic diseases].
    Poriadin GV; Salmasi ZhM; Makarkov AI
    Biull Eksp Biol Med; 1998 Apr; 125(4):434-6. PubMed ID: 9631730
    [No Abstract]   [Full Text] [Related]  

  • 2. [Activation processes in the lymphocytes of patients with latent sensitization].
    Poriadin GV; Orshanko AM; Salmasi ZhM; Latysheva TV; Kazimirskiĭ AN
    Patol Fiziol Eksp Ter; 2009; (1):23-5. PubMed ID: 19382620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of specific immunotherapy on peripheral T-lymphocytes in atopic patients].
    Anania A; Marino G; Cascio G
    Minerva Med; 1996 Jun; 87(6):263-7. PubMed ID: 8700354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of specific immunotherapy on the structural properties of the lymphocyte membranes in atopic diseases].
    Cherkashin SIu; Nagornaia IN; Tananko EM; Dymshits LB; Nosikova TA
    Ter Arkh; 1989; 61(7):95-7. PubMed ID: 2588151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased activation-induced cell death of high IFN-gamma-producing T(H)1 cells as a mechanism of T(H)2 predominance in atopic diseases.
    Akkoc T; de Koning PJ; Rückert B; Barlan I; Akdis M; Akdis CA
    J Allergy Clin Immunol; 2008 Mar; 121(3):652-658.e1. PubMed ID: 18328893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunotherapy as a method of causal treatment of atopic bronchial asthma].
    Romański B
    Pol Tyg Lek; 1975 Feb; 30(5):207-10. PubMed ID: 1114118
    [No Abstract]   [Full Text] [Related]  

  • 7. Normally suppressing CD40 coregulatory signals delivered by airway macrophages to TH2 lymphocytes are defective in patients with atopic asthma.
    Tang C; Ward C; Reid D; Bish R; O'byrne PM; Walters EH
    J Allergy Clin Immunol; 2001 May; 107(5):863-70. PubMed ID: 11344354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanisms of immunotropic effect of the drug composition Taban-Arshan (Tibet medicine) on lymphocytes of patients with early rheumatoid arthritis and atopic bronchial asthma].
    Semenova LIu; Salmasi ZhM; Kazimirskiĭ AN; Poriadin GV
    Patol Fiziol Eksp Ter; 2005; (1):23-5. PubMed ID: 15801236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A caspase-independent pathway of MHC class II antigen-mediated apoptosis of human B lymphocytes.
    Drénou B; Blancheteau V; Burgess DH; Fauchet R; Charron DJ; Mooney NA
    J Immunol; 1999 Oct; 163(8):4115-24. PubMed ID: 10510346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Where do we stand: the basic treatment of asthma and atopy: are we making backward progresses?
    Panzani RC; Ariano R; Saraga J
    Eur Ann Allergy Clin Immunol; 2005 Sep; 37(7):262-70. PubMed ID: 16285231
    [No Abstract]   [Full Text] [Related]  

  • 11. Allergens induce apoptosis in lymphocytes from atopic patients.
    Guerra F; Carracedo J; Madueño JA; Sanchez-Guijo P; Ramírez R
    Hum Immunol; 1999 Sep; 60(9):840-7. PubMed ID: 10527391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The extracorporeal immunopharmacotherapy of severe glucocorticoid-dependent atopic diseases].
    Kurbacheva OM; Poroshina IuA; Chitaeva VG; Leskov VP; Prozorovskiĭ NS; Fedenko ES; Gushchin IS
    Ter Arkh; 1992; 64(8):73-6. PubMed ID: 1440403
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunological mechanisms of recovery from an acute stage in patients with atopic bronchial asthma.
    Poryadin GV; Zhuravleva NE; Salmasi JM; Kazimirsky AN; Semenova LY; Polner SA; Chervinskaya TA
    Russ J Immunol; 2002 Oct; 7(3):259-64. PubMed ID: 12674936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atopic allergy and other hypersensitivities editorial overview: technological advances and new insights into pathogenesis prelude novel therapeutic strategies.
    Romagnani S
    Curr Opin Immunol; 1995 Dec; 7(6):745-50. PubMed ID: 8679114
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytokine production, activation marker, and skin homing receptor in children with atopic dermatitis and bronchial asthma.
    Antúnez C; Torres MJ; Mayorga C; Corzo JL; Jurado A; Santamaría-Babi LF; Vera A; Blanca M
    Pediatr Allergy Immunol; 2006 May; 17(3):166-74. PubMed ID: 16672002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of eosinophilia in atopic pathology].
    Magnan A; Vervloet D
    Med Trop (Mars); 1998; 58(4 Suppl):444-6. PubMed ID: 10410363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dendritic cells: orchestration of the immune response].
    Martinon-Ego C; Berthier R
    Ann Biol Clin (Paris); 2000; 58(5):541-56. PubMed ID: 11022098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell and eosinophil activation in mild and moderate atopic and nonatopic children's asthma in remission.
    Pumputiene I; Emuzyte R; Dubakiene R; Firantiene R; Tamosiunas V
    Allergy; 2006 Jan; 61(1):43-8. PubMed ID: 16364155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
    Bijl M; van Lopik T; Limburg PC; Spronk PE; Jaegers SM; Aarden LA; Smeenk RJ; Kallenberg GG
    J Autoimmun; 1998 Oct; 11(5):457-63. PubMed ID: 9802929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An evaluation of the long-term effect of clustered immunotherapy in house-dust-mite-sensitive adult bronchial asthma].
    Nagata M; Tanaka K
    Arerugi; 2001 May; 50(5):435-9. PubMed ID: 11436329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.